New guideline on syncope published in Germany

10

Jun 2020

The German Society for Neurology (DGN) has published a new version of the S1 guideline "Syncope." It is valid until January 2025.

As outlined in the guideline, in the case of a brief loss of consciousness (syncope), it makes more sense to have a uniform diagnostic process that should be independent of whether cardiologists, neurologists, or others see the patient first. A standardized procedure in line with the guidelines can reduce the number of hospital days, the number of medical and laboratory examinations, and helps to save costs in the health care of patients with syncope. A uniform approach should also guarantee that the patient receives adequate therapy as quickly as possible.

According to the guideline, the clarification of short loss of consciousness includes basic diagnostics and, if necessary, further examinations. The basic diagnosis consists of a detailed anamnesis and external anamnesis, a physical examination, a twelve-lead ECG, and an active standing test for at least three minutes, the so-called shortened Schellong test.

In the case of recurrent syncope without prodrome and with the risk of injury, an implantable event recorder should be considered to determine the indications for a pacemaker.

The guideline in German can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

09

Mar 2022

On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more

18

Feb 2022

Dutch Organization for Health Research and Development, ZonMw awarded eight projects under the "Healthcare Evaluation and Appropriate Use" program, including two projects for geriatric care, two projects for cancer, per one project for cardiovascular, neurovascular, and dermatology care.

Read more

14

Feb 2022

On January 28, 2022, the Institute for the Hospital Remuneration System (InEK) has published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2021. The medical technologies belonging to the cardiovascular, ENT, eHealth, gastrointestinal, neuromodulation, neurovascular, orthopedic, and other technology groups obtained positive status 1.

Read more